Prognosis

China Picks UAE to Make Millions of Vaccines, Boosting Gulf Ties

UAE becomes first country to produce Sinopharm overseas
Sinopharm, G42 JV aims for total capacity of 200m doses/year

China Approves Sinopharm's Covid Vaccine for General Use

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Sylvia Westall, Adveith Nair, and Farah Elbahrawy

March 28, 2021 at 11:20 AM UTC

Updated on

March 29, 2021 at 6:24 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

China is partnering with the United Arab Emirates to make millions of doses of its state-backed Sinopharm vaccine, in a deal that takes manufacturing of the shot overseas for the first time and deepens Beijing’s influence in the Middle East.